18FDG–PET–CT improves breast cancer staging

December 18, 2012

A prospective study has shown fluorodeoxyglucose positron emission tomography/computed tomography (18FDG-PET-CT) to be a powerful tool for the detection of nodal and distant metastatic disease in patients with breast cancer.